Qiqi Zhang
Beijing, 100053, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Gut microbiota-derived extracellular vesicles: bridging microbial-host crosstalk in metabolic disorders.
Journal: Cell communication and signaling : CCS
Published: March 29, 2026
The microbiota-gut-brain axis: novel mechanisms and therapeutic frontiers in obesity and type 2 diabetes.
Journal: NPJ biofilms and microbiomes
Published: January 19, 2026
The association between interleukin family and diabetes mellitus and its complications: An overview of systematic reviews and meta-analyses.
Journal: Diabetes research and clinical practice
Published: November 21, 2023
Mechanism of traditional Chinese medicine in elderly diabetes mellitus and a systematic review of its clinical application.
Journal: Frontiers in pharmacology
Published: November 15, 2023
Is non-alcoholic fatty liver disease a sign of left ventricular diastolic dysfunction in patients with type 2 diabetes mellitus? A systematic review and meta-analysis.
Journal: BMJ open diabetes research & care
Published: October 27, 2022
Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes.
Journal: Frontiers in immunology
Published: February 25, 2022
The mechanism of berberine alleviating metabolic disorder based on gut microbiome.
Journal: Frontiers in cellular and infection microbiology
Published: January 14, 2022
The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway.
Journal: Frontiers in pharmacology
Published: August 26, 2015
Showing 1-8 of 8
Last Updated: 09/26/2026